Skip to main content

Immunosuppressive Drugs: Do They Have Any Role in the Treatment of IBD?

(A)

  • Chapter
Inflammatory Bowel Diseases 1990

Part of the book series: Developments in Gastroenterology ((DIGA,volume 11))

  • 53 Accesses

Abstract

After 20 years the question of immunosuppressives in the management of inflammatory bowel disease is no longer a subject for a debate. The scientific evidence is clear and incontrovertible that these drugs are effective in both Crohn’s disease and ulcerative colitis. The lack of acceptance by the medical community is based on: 1) a failure to carefully review uncontrolled and controlled trials; 2) a lack of personal experience in treating patients with these agents; and 3) an unfounded fear of toxicity which has not been observed. The evidence of efficacy from published controlled and uncontrolled trials will be presented with emphasis on the personal series of Dr. Korelitz and myself.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  1. Sachar DB, Present DH (1978). Immunotherapy in inflammatory bowel disease. Med Clin N Amer 62:173–183.

    PubMed  CAS  Google Scholar 

  2. Kozarek RA, Patterson DJ, Gelfand MD et al (1989). Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Int Med 110:353–356.

    PubMed  CAS  Google Scholar 

  3. Brynskov J, Freund L, Rasmussen SN et al (1989). A placebo-controlled, double blind randomized trial of cyclosporin therapy in active chronic Crohn’s disease. N Engl J Med 321:845–850.

    Article  PubMed  CAS  Google Scholar 

  4. Mackay IR, Weiden S, Ungar B (1964). Treatment of active chronic hepatitis and lupoid hepatitis with 6-mercaptopurine and azathioprine. Lancet 1:899–902.

    Article  PubMed  CAS  Google Scholar 

  5. Lennard-Jones JE (1981). Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn’s disease. Dig Dis Sci 26:364–368.

    Article  PubMed  CAS  Google Scholar 

  6. Drucker WR, Jeejeebhoy KN (1970). Azathioprine: an adjunct to surgical therapy of granulomatous enteritis. Ann Surg 172:618–625.

    Article  PubMed  CAS  Google Scholar 

  7. Present DH (1981). 6-mercaptopurine and other immunosuppressive agents in the treatment of Crohn’s disease and ulcerative colitis. Gastro Clin of N Amer 1857–71.

    Google Scholar 

  8. Summers RW, Switz DM, Sessions JT Jr (1979). National Cooperative Crohn’s Disease Study: results of drug treatment. Gastro 77:847–869.

    CAS  Google Scholar 

  9. Present DH, Korelitz BI, Wisch N et al (1980). Treatment of Crohn’s disease with 6-mercaptopurine. A long term randomized double blind study. N Engl J Med 302:981–987.

    Article  PubMed  CAS  Google Scholar 

  10. Nyman M, Hansson I, Eriksson S (1985). Long term immunosuppressive treatment in Crohn’s disease. Scand J Gastroenterol 20:1197–1203.

    Article  PubMed  CAS  Google Scholar 

  11. Goldstein F (1987). Immunosuppressant therapy of inflammatory bowel disease. J Clin Gastroenterol 9:654–658.

    Article  PubMed  CAS  Google Scholar 

  12. Present DH, Chapman ML, Rubin PH (1988). Efficacy of 6-mercapto-purine in refractory ulcerative colitis (abstract). Gastro 94A:359.

    Google Scholar 

  13. Singleton JW (1981). Azathioprine has a very limited role in the treatment of Crohn’s disease. Dig Dis Sci 26:368–371.

    Article  PubMed  CAS  Google Scholar 

  14. Malchow H, Ewe K, Brandes JW et al (1984). European Cooperative Crohn’s Disease Study: results of drug treatment. Gastroenterol 86:249–266.

    CAS  Google Scholar 

  15. Verhave Mr Winter HS, Grand RJ (1987). Efficacy and safety of azathioprine in children with inflammatory bowel disease (abstract). Gastro 92:1682.

    Google Scholar 

  16. Present DH, Meltzer SJ, Krumholz MP. 6-mercaptopurine in the management of inflammatory bowel disease: short and long term toxicity. Annals Internal Medicine; in press. October 1989.

    Google Scholar 

  17. Kinlen LJ (1985). Incidence of cancer in lupoid arthritis and other disorders after immunosuppressive therapy. Am J Med Suppl 1A 2:44–49.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Present, D.H. (1990). Immunosuppressive Drugs: Do They Have Any Role in the Treatment of IBD?. In: Rachmilewitz, D., Zimmerman, J. (eds) Inflammatory Bowel Diseases 1990. Developments in Gastroenterology, vol 11. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1980-8_24

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1980-8_24

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7385-1

  • Online ISBN: 978-94-009-1980-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics